NO126864B - - Google Patents

Download PDF

Info

Publication number
NO126864B
NO126864B NO00594/71A NO59471A NO126864B NO 126864 B NO126864 B NO 126864B NO 00594/71 A NO00594/71 A NO 00594/71A NO 59471 A NO59471 A NO 59471A NO 126864 B NO126864 B NO 126864B
Authority
NO
Norway
Prior art keywords
methyl
acyl
group
indolyl
general formula
Prior art date
Application number
NO00594/71A
Other languages
English (en)
Inventor
Hisao Yamamoto
Masaru Nukao
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of NO126864B publication Critical patent/NO126864B/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B19/00Liquid-phase epitaxial-layer growth
    • C30B19/02Liquid-phase epitaxial-layer growth using molten solvents, e.g. flux
    • C30B19/04Liquid-phase epitaxial-layer growth using molten solvents, e.g. flux the solvent being a component of the crystal composition
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B19/00Liquid-phase epitaxial-layer growth
    • C30B19/06Reaction chambers; Boats for supporting the melt; Substrate holders
    • C30B19/061Tipping system, e.g. by rotation
    • CCHEMISTRY; METALLURGY
    • C30CRYSTAL GROWTH
    • C30BSINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/10Inorganic compounds or compositions
    • C30B29/40AIIIBV compounds wherein A is B, Al, Ga, In or Tl and B is N, P, As, Sb or Bi
    • C30B29/42Gallium arsenide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Metallurgy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydraulic Turbines (AREA)

Description

Fremgangsmåte til fremstilling av l-acyl-3-indolylalifatiske syreestere.
Foreliggende oppfinnelse vedrører en ny fremgangsmåte til fremstilling av l-acyl-3-indolylalifatiske syreestere med den generelle formel:
hvor R^ er en alkylgruppe, halogensubstituert alkylgruppe eller alke-
nylgruppe med opptil. 10 karbonatorner. R- og R er like eller forskjel-5 •'
lige og er et hydrogenatom eller en lavere alkylgruppe, Br er. en lavere alkoksygruppe med opptil 4 karbonatomer, en benzyloksy- eller tetrahydropyranyloksygruppe, R^ er en laverealkyl-, laverealkoksy-eller laverealkyltiogruppe, et halogenatom eller et hydrogenatom, m er 0 eller 1, og n er 0 eller et helt tall fra 1 til 3, men m og n kan.ikke samtidig være 0. •
Syntesen av indolkomponenter med N-stilliriger substituert med acylgrupper, er f.eks. beskrevet i Elderfield: "Heterocyclic Compounds", Vol. 3 (1952), kapittel 1, sidene 1 - 247, og i W.C. Sampter og F.M Miller: "Chemistry of Heterocyclic Compounds with Indole and Carbazole Systems" (1954), sidene 1 - 69. Syntesen av N-acylindol-forbindelser ifølge foreliggende fremgangsmåte er imidlertid ikke tidligere beskrevet.
Ifølge foreliggende oppfinnelse er det tilveiebragt en ny fremgangsmåte og denne er kjennetegnet ved at et fenylhydrazonderivat med den generelle formel: hvor R^, R^, R^, R^, m og n er som angitt ovenfor, omsettes med en acylforbindelse med den generelle formel:
hvor B?~ har den samme betydning som angitt ovenfor, og Y er et halogenatom eller gruppen -O.CO.R''', hvor R"*" har den ovenfor angitte betydning.
Egnede oppløsningsmidler som kan anvendes i ovennevnte fremgangsmåte er inerte oppløsningsmidler, organiske syrer og organiske syreestere. Som inerte oppløsningsmidler kan manfieks. anvende benzen, toluen, xylen, cykloheksan, tetrahydrofuran og heksan, som organiske syrer, f.eks. eddiksyre, kloreddiksyre, propionsyre, smørsyre, kapro-insyre og heptanoinsyre, og som organiske syreestere f.eks. etylklor-acetat, metylbutyrat, metylakrylat, metylvalerat og metylsorbat.

Claims (1)

  1. Som acylforbindelsen med formelen'-III er det mest vanlig å anvende acylklorid. Man kan dessuten anvende acylbromid eller syre-anhydridet. Reaksjonstemperaturen varierer fra ^30° 150°C, fortrinnsvis fra 80° - 120°C. Reaksjonen vil vanligvis, være fullstendig i løpet av et par timer. Hvis man etter fullstendig reaksjon.enten konsentrerer opp-løsningsmidlet eller tilsetter eddiksyre, vann eller petroleter, så vil det ønskede produkt bli utfelt, hvoretter dette kan renses ved konsentrasjon etter ekstraksjon med eter, benzen eller kloroform. Alle fremstilte l-acyl-3-indolylålifatiske syreestere er nye forbindelser og har smertestillende og feberstillende virkninger. Noen av disse estere, som f.eks. t-butylester, benzylester og tetrahydro-pyranylester kan videre hydrolyseres ved egnet béhandling til 1-acyl-3-indolylalifatiske syrer. De frie syrer har' høyere terapeutisk akti-vitet enn esterene. Foreliggende fremgangsmåte skal illustreres ved følgende eksempler.
    Eksempel 1 2.5 g p-metoksyfenylhydrazonet av metylevulinat ble tilsatt 50 ml iseddik. Oppløsningen ble så dråpevis tilsatt 0.9 g acetylklorid og ble så holdt oppvarmet på 80°C i 3 timer. Blandingen ble deretter under omrøring tilsatt 50 ml kaldt vann,, hvorved man fikk dannet en oljeaktig substans. Denne ble ekstrahert med eter, og man oppnådde metyl-l-acetyl-2-metyl-5-metoksy-3-indolylacetat. Infrarødt absorb-sjonsspektrum av dette produkt var i full overensstemmelse med spektret fra et standardprodukt fremstilt ved acetylering av metyl-2-metyl-5-metoksy-3-indolylacetat.
    Eksempel 2 Ved å bruke 1.2 g eddiksyreanhydrid istedenfor 0.9 g acetyl--klorid i fremgangsmåten i eksempel 1,. fikk man fremstilt metyl-1-acetyl-2-metyl-5-metoksy-3-indolylacetat. Fremgangsmåte til fremstilling av 1-acy1-3-indolylalifatiske syreestere med den generelle formel:
    hvor R er en alkylgruppe, halogensubstituert alkylgruppe eller alke- . nylgruppe med opptil 10 karbonatomer, R og R er like eller for-skjellige og er et hydrogenatom eller en lavere alkylgruppe, R 5 er en lavere alkoksygruppe med opptil 4 karbonatomer, en benzyloksy- eller tetrahydropyranyloksygruppe, R^ er en laverealkyl-, laverealkoksy-eller laverealkyltiogruppe, et halogenatom eller et hydrogenatom, m er 0 eller 1, og n er 0 eller et helt tall fra 1 til 3, men m og n kan ikke samtidig være 0,.karakterisert ved at et fenylhydrazonderivat med den generelle formel: 2 ~Z C £
    hvor R , R , R , R , m og n er som angitt ovenfor, omsettes med en acylforbindelse med den generelle formel:
    hvor R<1> har den samme betydning som angitt ovenfor, og Y er et halogenatom eller gruppen -O.CO.R<1>, hvor R<1> har den ovenfor angitte betydning,
NO00594/71A 1966-01-12 1971-02-18 NO126864B (no)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP199966 1966-01-12
JP2730166 1966-04-28
JP2730066 1966-04-28
JP2812566 1966-05-02
JP2840066 1966-05-04
JP4059166 1966-06-21
JP4472466 1966-07-08
JP4472366 1966-07-08
JP5467466 1966-08-19
JP5467566 1966-08-19

Publications (1)

Publication Number Publication Date
NO126864B true NO126864B (no) 1973-04-02

Family

ID=27579471

Family Applications (3)

Application Number Title Priority Date Filing Date
NO00166327A NO126862B (no) 1966-01-12 1967-01-10
NO00595/71A NO126865B (no) 1966-01-12 1971-02-18
NO00594/71A NO126864B (no) 1966-01-12 1971-02-18

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO00166327A NO126862B (no) 1966-01-12 1967-01-10
NO00595/71A NO126865B (no) 1966-01-12 1971-02-18

Country Status (13)

Country Link
AT (4) AT283349B (no)
BE (1) BE692456A (no)
BR (1) BR6786134D0 (no)
CS (3) CS155156B2 (no)
DE (2) DE1618933A1 (no)
DK (1) DK134715B (no)
FI (1) FI49162C (no)
FR (1) FR7844M (no)
IL (1) IL27173A (no)
NL (1) NL146804B (no)
NO (3) NO126862B (no)
SE (2) SE307795B (no)
SU (1) SU375847A3 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU162374B (no) * 1969-04-03 1973-02-28
CZ300116B6 (cs) * 2006-12-05 2009-02-11 Zentiva, A. S. Zpusob cištení hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu

Also Published As

Publication number Publication date
DE1620441C3 (de) 1975-05-22
CS155157B2 (no) 1974-05-30
SE307795B (no) 1969-01-20
NL146804B (nl) 1975-08-15
NL6700300A (no) 1967-07-13
AT277995B (de) 1970-01-12
SE314985B (no) 1969-09-22
IL27173A (en) 1972-08-30
AT280991B (de) 1970-05-11
AT283349B (de) 1970-08-10
DE1620441A1 (de) 1970-08-27
BE692456A (no) 1967-06-16
BR6786134D0 (pt) 1973-12-26
AT277996B (de) 1970-01-12
NO126865B (no) 1973-04-02
CS155158B2 (no) 1974-05-30
DE1643506A1 (de) 1972-03-30
CS155156B2 (no) 1974-05-30
SU375847A3 (no) 1973-03-23
DE1643506B2 (de) 1973-01-04
FI49162C (fi) 1975-04-10
DE1618933A1 (de) 1972-03-16
FR7844M (no) 1970-06-01
NO126862B (no) 1973-04-02
DK134715C (no) 1977-05-31
DE1620441B2 (de) 1974-09-19
DK134715B (da) 1977-01-03

Similar Documents

Publication Publication Date Title
FI107450B (fi) Menetelmä finasteridin valmistamiseksi
JPS5826744B2 (ja) シンキナプロピオンサン エステルユウドウタイノセイゾウホウ
NO162587B (no) Anordning for aa overvaake tilstedevaerelsen av en person i en seng.
NO126864B (no)
NO144481B (no) Utforming av et oensket bruddsted for en under innertrykk staaende beholder.
NO304942B1 (no) Kinider og fremgangsmÕte for fremstilling av derivater av kininsyre
Su et al. Synthesis of Bromo-substituted Indoxyl Esters for Cytochemical Demonstration of Enzyme Activity1
JPH01213268A (ja) 1‐アルキル‐5‐ニトロイミダゾールの製造方法
NO125272B (no)
NO130461B (no)
GB815279A (en) Novel benzomorpholone derivatives and a process for the manufacture thereof
US3910958A (en) Process for preparing arylacetic acids and esters thereof
Goodman et al. Coformational aspects of polypeptide structure XL. The synthesis of poly [(S)‐thiazolidine‐4‐carboxylic acid]
JPS5576852A (en) Novel derivative of anthranilic acid
JPH01305071A (ja) オキサゾロン誘導体の製造方法
Goldsmith et al. The synthesis of DL-Methionine
Haslewood et al. Bile salts of the green turtle Chelonia mydas (L.)
US3647785A (en) Novel 3-indolylaliphatic acid anhydrides
KR830007660A (ko) 5,6,7,7a-테트라하이드로-4H-티에노(3,2-c)-피리딘-2-온 유도체의 제조방법
JPS5520714A (en) Novel preparation of dl-2-amino-4-methylphosphinobutylic acid
US2774782A (en) Fl-glycolylphenyl acrylonitriles and
Woodburn et al. The structure of 2, 4‐dihydroxypyridines
JPS5579344A (en) Derivative of 4-(4-hydroxyphenoxy)-2-pentenoic acid
ES440270A1 (es) Procedimiento para preparar imidas de esteres de acidos n- (aminometiliden)-tiolfosforicos y tionofosforicos.
IL34245A (en) Process for the preparation of a-) 1 - noble - 3 - indolyl (low elliptical carboxyls